Pankaj Mohan - Dec 11, 2023 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chairman, President and CEO, Director
Signature
/s/ John Harry Cross III, power of attorney
Stock symbol
SONN
Transactions as of
Dec 11, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2024, 09:55 PM
Previous filing
Oct 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +7.55K +101.63% 15K Dec 11, 2023 Direct F1, F2, F3
holding SONN Common Stock 3 Dec 11, 2023 By Child F3
holding SONN Common Stock 377 Dec 11, 2023 By Mohan Family Office F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 11, 2023, the Reporting Person was granted 7,554 restricted stock awards, which will be settled in shares of common stock, par value $0.0001. The shares in connection with the restricted stock award become fully vested on January 1, 2025.
F2 Includes unvested restricted stock awards.
F3 All amounts reflect the Issuer's 1:22 reverse stock split effective as of September 30, 2024.
F4 Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.